Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1525-1535

  Jaafar, Fatimah ^a   Righi, Elda ^b   Lindstrom, Victoria ^b   Linton, Christine ^b   Nohadani, Mahrokh ^a   Van Noorden, Susan ^a   Lloyd, Tyler ^a   Poznansky, Joshua ^a   Stamp, Gordon ^a   Dina, Roberto ^a   Coleman, Dulcie V ^a   Poznansky, Mark C ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER GROWTH; CANCER STAGING; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS; WESTERN BLOTTING;

EID: 73549108751     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090295     Document Type: Article

References (33)

1. Cannon MJ, Santin AD, O'Brien TJ: Immunological treatment of ovarian cancer. Curr Opin Obstet Gynecol 2004, 16:87-92
2. Santin AD, Bellone S, Underwood LJ, O'Brien TJ, Ravaggi A, Pecorelli S, Cannon MJ: Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer. Minerva Ginecol 2002, 54:133-144
3. Waldmann TA: Effective cancer therapy through immunomodulation. Annu Rev Med 2006, 57:65-81
4. Muñoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000, 19:1-5
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19
6. Castelli C, Maeurer MJ: The T-cell response in patients with cancer. Adv Cancer Res 2002, 86:149-193
7. Eiben GL, Velders MP, Kast WM: The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy. Adv Cancer Res 2002, 86:113-148
8. Sheu BC, Chang WC, Lin HH, Chow SN, Huang SC: Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia. J Obstet Gynaecol Res 2007, 33:103-113
9. Majka M, Drukala J, Lesko E, Wysoczynski M, Jenson AB, Ratajczak MZ: SDF-1 alone and in co-operation with HGF regulates biology of human cervical carcinoma cells. Folia Histochem Cytobiol 2006, 44:155-164
10. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004, 14:171-179
11. Kryczek I, Wei S, Keller E, Liu R, Zou W: Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007, 292:C987-C995
12. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998, 392:565-568
13. Singh S, Sadanandam A, Singh RK: Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 26:453-467, 2007
14. Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT: Active movement of T cells away from a chemokine. Nat Med 2000, 6:543-548
15. Vianello F, Olszak IT, Poznansky MC: Fugetaxis: active movement of leukocytes away from a chemokinetic agent. J Mol Med 2005, 83:752-763
16. Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, Curiel TJ: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001, 7:1339-1346
17. Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palù G, Irimia D, Toner M, Weissleder R, Poznansky MC: Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol 2006, 176:2902-2914
18. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10:942-949
19. hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 2007, 121:1749-1755
20. Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP: CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer 2007, 17:676-686
21. Zhang JP, Lu WG, Ye F, Chen HZ, Zhou CY, Xie X: Study on CXCR4/ SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma. Int J Gynecol Cancer 2007, 17:478-483
22. Dunussi-Joannopoulos K, Zuberek K, Runyon K: Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. Blood 2002, 100:1551-1558
23. Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, Huntsman DG, Coukos G, Gilks CB: Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol 2009, 22:393-402
24. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004, 64:8420-8427
25. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis.[ see comment]. Nature 2001, 410:50-56
26. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR: Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002, 62:5930-5938
27. De Falco V, Guarino V, Avilla E, Castellone MD, Salerno P, Salvatore G, Faviana P, Basolo F, Santoro M, Melillo RM: Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res 2007, 67:11821-11829
28. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F: Involvement of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 2008, 122:91-99
29. Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P, Spoto C, Zingaretti C, Sisti V, Alessandroni P, Giordani P, Cicetti A, D'Emidio S, Morini S, Ruzzo A, Magnani M, Tonini G, Rabitti C, Graziano F: Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer 2008, 44:1875-1882
30. + regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata. J Immunol 2008, 180:7681-7686
31. Balabanian K, Levoye A, Klemm L, Lagane B, Hermine O, Harriague J, Baleux F, Arenzana-Seisdedos F, Bachelerie F: Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest 2008, 118:1074-1084
32. Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ: Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 2005, 19:469-483
33. International Agency for Research on Cancer/World Health Organization: Handbooks of Cancer Prevention, vol 10. Cervical Cancer Screening. Lyon, France, IARC Press, 2005, pp 469-483